Product Details
Place of Origin: China
Brand Name: Sunshine
Certification: ISO,COA
Model Number: 5985-28-4
Payment & Shipping Terms
Minimum Order Quantity: Negotiation
Price: Negotiation
Packaging Details: Bag,Drum
Delivery Time: 7-15 days
Payment Terms: L/C, D/A, T/T, Western Union
Supply Ability: TON
CAS NO:: |
5985-28-4 |
Appearance:: |
White Fine Powder |
Molecular Formula:: |
C9H14ClNO2 |
Molecular Weight:: |
203.66600 |
EINECS NO:: |
227-804-6 |
MDL NO:: |
MFCD00050566 |
CAS NO:: |
5985-28-4 |
Appearance:: |
White Fine Powder |
Molecular Formula:: |
C9H14ClNO2 |
Molecular Weight:: |
203.66600 |
EINECS NO:: |
227-804-6 |
MDL NO:: |
MFCD00050566 |
Product Description:
Product Name: Synephrine hydrochloride CAS NO: 5985-28-4
Synonyms:
2-methylamino-1-(4-hydroxyphenyl)-ethanol hydrochloride;
(+-)-1-(4-hydroxy-phenyl)-2-methylamino-ethanol,hydrochloride;
4-(1-Hydroxy-2-(methylamino)ethyl)phenol hydrochloride;
Chemical & Physical Properties:
Appearance: White fine powder
Assay :≥99.0%
Boiling Point: 341.1℃ at 760 mmHg
Melting Point: 147-150℃
Flash Point: 163.4℃
Storage Condition: Refrigerator
Safety Information:
HS Code: 2922199090
A α-adrenergic receptor agonist, vasoconstrictor. Synephrine Hcl(Oxedrine) is an alkaloid; synephrine produces most of its biological effects by acting as an agonist at adrenergic receptors.IC50 value:Target: adrenergic receptor agonistThere is some evidence that synephrine also has weak activity at 5-HT receptors, and that it interacts with TAAR1 (trace adrenergic amine receptors). d-synephrine inhibited the uptake of [3H]-norepinephrine with an IC50 = 5.8 μM; l-synephrine was less potent (IC50 = 13.5 μM). d-Synephrine also competitively inhibited the binding of nisoxetine[m] to rat brain cortical slices, with a Ki = 4.5 μM; l-synephrine was less potent (Ki = 8.2 μM). In experiments on the release of [3H]-norepinephrine from rat brain cortical slices, however, the l-isomer of synephrine was a more potent enhancer of the release (EC50 = 8.2 μM) than the d-isomer (EC50 = 12.3 μM). This enhanced release by l-synephrine was blocked by nisoxetine.
If you are interested in our products or have any questions, please feel free to contact us!
Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.